In terms of market performance, Immuneering Corp had a somewhat inconsistent run in. The highest value for the stock in the past year was $8.89 on 12/04/23, while the lowest value was $1.00 on 08/16/24.
52-week price history of IMRX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Immuneering Corp’s current trading price is -77.50% away from its 52-week high, while its distance from the 52-week low is 100.00%. The stock’s price range for this period has remained between $1.00 and $8.89. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.94 million for the day, which was noticeably lower compared to the shares’ average daily volume of 6.21 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Immuneering Corp (IMRX) has experienced a quarterly rise of 60.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 59.30M and boasts a workforce of 68 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.54, with a change in price of +0.46. Similarly, Immuneering Corp recorded 4,149,424 in trading volume during the last 100 days, posting a change of +29.87%.
IMRX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for IMRX stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.06.
IMRX Stock Stochastic Average
As of today, the raw stochastic average of Immuneering Corp over the past 50 days is 35.34%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 6.21%. Additionally, the Stochastic %K and %D values for the company were 14.84% and 24.30%, respectively, over the past 20 days.
IMRX Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded a decrease of -72.79%. However, over the last six months, the performance has been weaker by 4.44%. The price of IMRX decreased -0.99% over the last 30 days. And in the last five days, it has fallen by -18.37%.
